This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Rhoen Klinikum AG's Median PS Value or its related term are showing as below:
XTER:RHK'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.38 Med: 0.63 Max: 1
Current: 0.49
During the past 13 years, the highest Price to Median PS Value of Rhoen Klinikum AG was 1.00. The lowest was 0.38. And the median was 0.63.
XTER:RHK's Price-to-Median-PS-Value is ranked better than 78.88% of 232
companies
in the Healthcare Providers & Services industry
Industry Median: 0.74
vs XTER:RHK: 0.49
Rhoen Klinikum AG Median PS Value Historical Data
The historical data trend for Rhoen Klinikum AG's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Rhoen Klinikum AG's Median PS Value
For the Medical Care Facilities subindustry, Rhoen Klinikum AG's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rhoen Klinikum AG's Price-to-Median-PS-Value Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Rhoen Klinikum AG's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 1.1993.
Rhoen Klinikum AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €21.954.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rhoen Klinikum AG (XTER:RHK) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Rhoen Klinikum AG's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
12.90
/
26.33
=
0.49
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rhoen Klinikum AG Median PS Value Related Terms
Thank you for viewing the detailed overview of Rhoen Klinikum AG's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Rhoen Klinikum AG provides medical care focused in five key areas: cardiovascular medicine, neuromedicine, oncology, pulmonary diseases, and orthopedic and trauma surgery. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on an outpatient basis. Rhoen Klinikum generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the largest proportions of revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTER:RHK has been successfully added to your 